Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Shares Issued (2016 - 2025)

Icu Medical (ICUI) has disclosed Shares Issued for 17 consecutive years, with $134000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued fell 97.35% year-over-year to $134000.0, compared with a TTM value of $6.1 million through Dec 2025, down 44.18%, and an annual FY2025 reading of $6.1 million, down 44.18% over the prior year.
  • Shares Issued was $134000.0 for Q4 2025 at Icu Medical, down from $5.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $5.8 million in Q2 2025 and bottomed at $18000.0 in Q2 2022.
  • Average Shares Issued over 5 years is $2.2 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Shares Issued surged 11355.56% in 2023, then crashed 97.35% in 2025.
  • Year by year, Shares Issued stood at $2.4 million in 2021, then plummeted by 63.47% to $879000.0 in 2022, then soared by 103.53% to $1.8 million in 2023, then soared by 182.62% to $5.1 million in 2024, then plummeted by 97.35% to $134000.0 in 2025.
  • Business Quant data shows Shares Issued for ICUI at $134000.0 in Q4 2025, $5.8 million in Q2 2025, and $133000.0 in Q1 2025.